TP53 and colorectal carcinoma: Yu et al. reported that autophagy-related pathways are enriched and activated in CRC patients and can induce cancer chemoresistance21; Sakanashi et al. suggested that autophagy is upregulated in aggressive CRCs, and p53 mutation may lead to the upregulation of autophagy22.